Copyright Reports & Markets. All rights reserved.

Global Antisense and RNAi Therapeutics Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Antisense and RNAi Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Antisense and RNAi Therapeutics
      • 1.2 Antisense and RNAi Therapeutics Segment by Type
        • 1.2.1 Global Antisense and RNAi Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 RNA Interference
        • 1.2.3 Antisense RNA
      • 1.3 Antisense and RNAi Therapeutics Segment by Application
        • 1.3.1 Antisense and RNAi Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
      • 1.4 Global Antisense and RNAi Therapeutics Market by Region
        • 1.4.1 Global Antisense and RNAi Therapeutics Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Antisense and RNAi Therapeutics Market Size
        • 1.5.1 Global Antisense and RNAi Therapeutics Revenue (2014-2025)
        • 1.5.2 Global Antisense and RNAi Therapeutics Production (2014-2025)

      2 Global Antisense and RNAi Therapeutics Market Competition by Manufacturers

      • 2.1 Global Antisense and RNAi Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Antisense and RNAi Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Antisense and RNAi Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Antisense and RNAi Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Antisense and RNAi Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Antisense and RNAi Therapeutics Market Concentration Rate
        • 2.5.2 Antisense and RNAi Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Antisense and RNAi Therapeutics Production Market Share by Regions

      • 3.1 Global Antisense and RNAi Therapeutics Production Market Share by Regions
      • 3.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Antisense and RNAi Therapeutics Production
        • 3.4.1 North America Antisense and RNAi Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Antisense and RNAi Therapeutics Production
        • 3.5.1 Europe Antisense and RNAi Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Antisense and RNAi Therapeutics Production (2014-2019)
        • 3.6.1 China Antisense and RNAi Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Antisense and RNAi Therapeutics Production (2014-2019)
        • 3.7.1 Japan Antisense and RNAi Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Antisense and RNAi Therapeutics Consumption by Regions

      • 4.1 Global Antisense and RNAi Therapeutics Consumption by Regions
      • 4.2 North America Antisense and RNAi Therapeutics Consumption (2014-2019)
      • 4.3 Europe Antisense and RNAi Therapeutics Consumption (2014-2019)
      • 4.4 China Antisense and RNAi Therapeutics Consumption (2014-2019)
      • 4.5 Japan Antisense and RNAi Therapeutics Consumption (2014-2019)

      5 Global Antisense and RNAi Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Antisense and RNAi Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Antisense and RNAi Therapeutics Price by Type (2014-2019)
      • 5.4 Global Antisense and RNAi Therapeutics Production Growth by Type (2014-2019)

      6 Global Antisense and RNAi Therapeutics Market Analysis by Applications

      • 6.1 Global Antisense and RNAi Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Antisense and RNAi Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Antisense and RNAi Therapeutics Business

      • 7.1 Tekmira Pharmaceuticals
        • 7.1.1 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.1.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Arbutus Biopharma
        • 7.2.1 Arbutus Biopharma Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.2.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Alnylam Pharmaceuticals
        • 7.3.1 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.3.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Antisense Therapeutics
        • 7.4.1 Antisense Therapeutics Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.4.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Silence Therapeutics
        • 7.5.1 Silence Therapeutics Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.5.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Isis Pharmaceuticals
        • 7.6.1 Isis Pharmaceuticals Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.6.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sirnaomics
        • 7.7.1 Sirnaomics Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.7.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Sirnaomics Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Santaris
        • 7.8.1 Santaris Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.8.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.8.3 Santaris Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Roche
        • 7.9.1 Roche Antisense and RNAi Therapeutics Production Sites and Area Served
        • 7.9.2 Antisense and RNAi Therapeutics Product Introduction, Application and Specification
        • 7.9.3 Roche Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Antisense and RNAi Therapeutics Manufacturing Cost Analysis

      • 8.1 Antisense and RNAi Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Antisense and RNAi Therapeutics
      • 8.4 Antisense and RNAi Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Antisense and RNAi Therapeutics Distributors List
      • 9.3 Antisense and RNAi Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Antisense and RNAi Therapeutics Market Forecast

      • 11.1 Global Antisense and RNAi Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Antisense and RNAi Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Antisense and RNAi Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Antisense and RNAi Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Antisense and RNAi Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Antisense and RNAi Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Antisense and RNAi Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Antisense and RNAi Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Antisense and RNAi Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Antisense and RNAi Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Antisense and RNAi Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Antisense and RNAi Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Antisense and RNAi Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Antisense and RNAi Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Antisense and RNAi Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Antisense and RNAi Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology.
        The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the near future.

        The global Antisense and RNAi Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Antisense and RNAi Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antisense and RNAi Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Tekmira Pharmaceuticals
        Arbutus Biopharma
        Alnylam Pharmaceuticals
        Antisense Therapeutics
        Silence Therapeutics
        Isis Pharmaceuticals
        Sirnaomics
        Santaris
        Roche

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        RNA Interference
        Antisense RNA

        Segment by Application
        Hospital
        Clinic

        Buy now